Yamazaki N - Search Results

1

Effects of non-amputative wide local excision on the local control and prognosis of in situ and invasive subungual melanoma.

Nakamura Y, Ohara K, Kishi A, Teramoto Y, Sato S, Fujisawa Y, Fujimoto M, Otsuka F, Hayashi N, Yamazaki N, Yamamoto A. Nakamura Y, et al. Among authors: yamazaki n. J Dermatol. 2015 Sep;42(9):861-6. doi: 10.1111/1346-8138.12923. Epub 2015 May 18. J Dermatol. 2015. PMID: 25982364

2

Clinical and pathological features of cutaneous malignant melanoma: a retrospective analysis of 124 Japanese patients.

Kuno Y, Ishihara K, Yamazaki N, Mukai K. Kuno Y, et al. Among authors: yamazaki n. Jpn J Clin Oncol. 1996 Jun;26(3):144-51. doi: 10.1093/oxfordjournals.jjco.a023198. Jpn J Clin Oncol. 1996. PMID: 8656554

3

HLA class I polymorphism and the susceptibility to malignant melanoma.

Muto M, Ohmura A, Nakano J, Yamazaki N, Yamamoto A, Ishihara K, Sasazuki T, Asagami C. Muto M, et al. Among authors: yamazaki n. Tissue Antigens. 1996 May;47(5):447-9. Tissue Antigens. 1996. PMID: 8795150 No abstract available.

4

Eccrine porocarcinoma with melanocyte colonization.

Nakanishi Y, Matsuno Y, Shimoda T, Wada T, Yamazaki N, Yamamoto A, Hirohashi S. Nakanishi Y, et al. Among authors: yamazaki n. Br J Dermatol. 1998 Mar;138(3):519-21. doi: 10.1046/j.1365-2133.1998.02137.x. Br J Dermatol. 1998. PMID: 9580812

5

Low frequency of neutralizing antibodies against natural interferon-beta during adjuvant therapy for Japanese patients with melanoma.

Kageshita T, Yamamoto A, Yamazaki N, Ishihara K, Ono T. Kageshita T, et al. Among authors: yamazaki n. J Dermatol Sci. 1999 Apr;19(3):208-12. doi: 10.1016/s0923-1811(98)00072-3. J Dermatol Sci. 1999. PMID: 10215194

6

A case of metastatic extramammary Paget's disease that responded to combination chemotherapy.

Yamazaki N, Yamamoto A, Wada T, Ishikawa M, Moriya Y, Nakanishi Y. Yamazaki N, et al. J Dermatol. 1999 May;26(5):311-6. doi: 10.1111/j.1346-8138.1999.tb03477.x. J Dermatol. 1999. PMID: 10380432

7

Dacarbazine, nimustine hydrochloride, cisplatin and tamoxifen combination chemotherapy for advanced malignant melanoma.

Yamazaki N, Yamamoto A, Wada T, Ishikawa M. Yamazaki N, et al. J Dermatol. 1999 Aug;26(8):489-93. doi: 10.1111/j.1346-8138.1999.tb02033.x. J Dermatol. 1999. PMID: 10487002

8

Malignant eccrine spiradenoma: a case report and review of the literature.

Ishikawa M, Nakanishi Y, Yamazaki N, Yamamoto A. Ishikawa M, et al. Among authors: yamazaki n. Dermatol Surg. 2001 Jan;27(1):67-70. Dermatol Surg. 2001. PMID: 11231249 Review.

9

Evaluation of 5-S-cysteinyldopa as a marker of melanoma progression: 10 years' experience.

Wakamatsu K, Kageshita T, Furue M, Hatta N, Kiyohara Y, Nakayama J, Ono T, Saida T, Takata M, Tsuchida T, Uhara H, Yamamoto A, Yamazaki N, Naito A, Ito S. Wakamatsu K, et al. Among authors: yamazaki n. Melanoma Res. 2002 Jun;12(3):245-53. doi: 10.1097/00008390-200206000-00008. Melanoma Res. 2002. PMID: 12140381

10

Cytotoxic T cell induction against human malignant melanoma cells using HLA-A24-restricted melanoma peptide cocktail.

Akiyama Y, Maruyama K, Nara N, Mochizuki T, Yamamoto A, Yamazaki N, Kawashima I, Nukaya I, Takesako K, Yamaguchi K. Akiyama Y, et al. Among authors: yamazaki n. Anticancer Res. 2004 Mar-Apr;24(2B):571-7. Anticancer Res. 2004. PMID: 15160996 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

778 results

Search Page

Filters